何氏眼科
(301103)
| 流通市值：32.40亿 | | | 总市值：32.40亿 |
| 流通股本：1.58亿 | | | 总股本：1.58亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 560,092,655.12 | 291,475,651.27 | 1,095,633,818.01 | 864,900,603.72 |
| 营业收入 | 560,092,655.12 | 291,475,651.27 | 1,095,633,818.01 | 864,900,603.72 |
| 二、营业总成本 | 505,466,143.59 | 249,890,953.57 | 1,092,731,743.26 | 820,811,241.56 |
| 营业成本 | 324,503,332.43 | 163,805,191.42 | 672,647,617.19 | 510,958,886.04 |
| 税金及附加 | 2,601,626.41 | 1,416,884.15 | 8,282,285.14 | 4,623,931.5 |
| 销售费用 | 79,760,169.6 | 38,332,856.94 | 182,460,680.23 | 133,215,308.06 |
| 管理费用 | 93,836,929.78 | 44,765,062.74 | 218,648,746.79 | 162,215,804.62 |
| 研发费用 | 6,120,724.03 | 2,814,695.66 | 18,105,528.86 | 13,724,401.11 |
| 财务费用 | -1,356,638.66 | -1,243,737.34 | -7,413,114.95 | -3,927,089.77 |
| 其中:利息费用 | 4,606,772.4 | 2,343,629.65 | 11,338,074.36 | 8,491,577.98 |
| 其中:利息收入 | 6,962,143.99 | 4,118,655.75 | 21,199,207.2 | 14,409,261.75 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 1,869,969.56 | -410,570.3 | 993,033.59 | 92,925 |
| 加:投资收益 | 4,032,222.49 | 1,339,625.23 | 453,353.14 | 741.66 |
| 资产处置收益 | -70,009.14 | -12,569.43 | 1,399,235.42 | 1,304,915.9 |
| 资产减值损失(新) | -546,141.14 | -415,816.42 | -1,694,352.48 | -676,466.41 |
| 信用减值损失(新) | -514,600.57 | -385,075.47 | -1,295,103.13 | -565,375.39 |
| 其他收益 | 2,633,787.69 | 660,753.56 | 3,402,244.35 | 3,029,943.12 |
| 四、营业利润 | 62,031,740.42 | 42,361,044.87 | 6,160,485.64 | 47,276,046.04 |
| 加:营业外收入 | 292,761.8 | 132,441.02 | 208,660.13 | 153,113.5 |
| 减:营业外支出 | 1,256,561.98 | 267,708.26 | 4,741,983.91 | 2,294,242.84 |
| 五、利润总额 | 61,067,940.24 | 42,225,777.63 | 1,627,161.86 | 45,134,916.7 |
| 减:所得税费用 | 17,500,523.03 | 11,567,173.34 | 36,903,019.51 | 34,603,309.2 |
| 六、净利润 | 43,567,417.21 | 30,658,604.29 | -35,275,857.65 | 10,531,607.5 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 43,567,417.21 | 30,658,604.29 | -35,275,857.65 | 10,531,607.5 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 44,324,593.65 | 32,531,877.2 | -27,398,159.61 | 16,375,500.3 |
| 少数股东损益 | -757,176.44 | -1,873,272.91 | -7,877,698.04 | -5,843,892.8 |
| 扣除非经常损益后的净利润 | 37,241,675.29 | 31,189,504.57 | -28,787,671.23 | 14,789,368.08 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.28 | 0.21 | -0.17 | 0.1 |
| (二)稀释每股收益 | 0.28 | 0.21 | -0.17 | 0.1 |
| 八、其他综合收益 | -19,381.89 | 591,621.26 | 3,764.36 | 72,240.81 |
| 归属于母公司股东的其他综合收益 | -19,381.89 | 591,621.26 | 3,764.36 | 72,240.81 |
| 九、综合收益总额 | 43,548,035.32 | 31,250,225.55 | -35,272,093.29 | 10,603,848.31 |
| 归属于母公司股东的综合收益总额 | 44,305,211.76 | 33,123,498.46 | -27,394,395.25 | 16,447,741.11 |
| 归属于少数股东的综合收益总额 | -757,176.44 | -1,873,272.91 | -7,877,698.04 | -5,843,892.8 |
| 公告日期 | 2025-08-28 | 2025-04-25 | 2025-04-25 | 2024-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |